• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

8p12干细胞骨髓增殖性疾病:t(6;8)易位产生的FOP-成纤维细胞生长因子受体1融合蛋白通过丝裂原活化蛋白激酶和磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号通路介导细胞存活。

8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.

作者信息

Guasch G, Ollendorff V, Borg J P, Birnbaum D, Pébusque M J

机构信息

Laboratoire d'Oncologie Moléculaire, INSERM U 119, IFR 57, Marseille, France.

出版信息

Mol Cell Biol. 2001 Dec;21(23):8129-42. doi: 10.1128/MCB.21.23.8129-8142.2001.

DOI:10.1128/MCB.21.23.8129-8142.2001
PMID:11689702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC99978/
Abstract

The FOP-fibroblast growth factor receptor 1 (FGFR1) fusion protein is expressed as a consequence of a t(6;8) (q27;p12) translocation associated with a stem cell myeloproliferative disorder with lymphoma, myeloid hyperplasia and eosinophilia. In the present report, we show that the fusion of the leucine-rich N-terminal region of FOP to the catalytic domain of FGFR1 results in conversion of murine hematopoietic cell line Ba/F3 to factor-independent cell survival via an antiapoptotic effect. This survival effect is dependent upon the constitutive tyrosine phosphorylation of FOP-FGFR1. Phosphorylation of STAT1 and of STAT3, but not STAT5, is observed in cells expressing FOP-FGFR1. The survival function of FOP-FGFR1 is abrogated by mutation of the phospholipase C gamma binding site. Mitogen-activated protein kinase (MAPK) is also activated in FOP-FGFR1-expressing cells and confers cytokine-independent survival to hematopoietic cells. These results demonstrate that FOP-FGFR1 is capable of protecting cells from apoptosis by using the same effectors as the wild-type FGFR1. Furthermore, we show that FOP-FGFR1 phosphorylates phosphatidylinositol 3 (PI3)-kinase and AKT and that specific inhibitors of PI3-kinase impair its ability to promote cell survival. In addition, FOP-FGFR1-expressing cells show constitutive phosphorylation of the positive regulator of translation p70S6 kinase; this phosphorylation is inhibited by PI3-kinase and mTOR (mammalian target of rapamycin) inhibitors. These results indicate that translation control is important to mediate the cell survival effect induced by FOP-FGFR1. Finally, FOP-FGFR1 protects cells from apoptosis by survival signals including BCL2 overexpression and inactivation of caspase-9 activity. Elucidation of signaling events downstream of FOP-FGFR1 constitutive activation provides insight into the mechanism of leukemogenesis mediated by this oncogenic fusion protein.

摘要

FOP-成纤维细胞生长因子受体1(FGFR1)融合蛋白是由t(6;8)(q27;p12)易位导致的,该易位与一种伴有淋巴瘤、髓样增生和嗜酸性粒细胞增多的干细胞骨髓增殖性疾病相关。在本报告中,我们表明FOP富含亮氨酸的N端区域与FGFR1催化结构域的融合通过抗凋亡作用使小鼠造血细胞系Ba/F3转变为不依赖因子的细胞存活状态。这种存活效应依赖于FOP-FGFR1的组成型酪氨酸磷酸化。在表达FOP-FGFR1的细胞中观察到STAT1和STAT3的磷酸化,但未观察到STAT5的磷酸化。FOP-FGFR1的存活功能因磷脂酶Cγ结合位点的突变而被消除。丝裂原活化蛋白激酶(MAPK)在表达FOP-FGFR1的细胞中也被激活,并赋予造血细胞不依赖细胞因子的存活能力。这些结果表明,FOP-FGFR1能够通过与野生型FGFR1相同的效应器保护细胞免受凋亡。此外,我们表明FOP-FGFR1使磷脂酰肌醇3(PI3)激酶和AKT磷酸化,并且PI3激酶的特异性抑制剂损害其促进细胞存活的能力。此外,表达FOP-FGFR1的细胞显示翻译正调节因子p70S6激酶的组成型磷酸化;这种磷酸化被PI3激酶和雷帕霉素哺乳动物靶点(mTOR)抑制剂抑制。这些结果表明翻译控制对于介导FOP-FGFR1诱导的细胞存活效应很重要。最后,FOP-FGFR1通过包括BCL2过表达和caspase-9活性失活在内的存活信号保护细胞免受凋亡。对FOP-FGFR1组成型激活下游信号事件的阐明为这种致癌融合蛋白介导的白血病发生机制提供了见解。

相似文献

1
8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.8p12干细胞骨髓增殖性疾病:t(6;8)易位产生的FOP-成纤维细胞生长因子受体1融合蛋白通过丝裂原活化蛋白激酶和磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号通路介导细胞存活。
Mol Cell Biol. 2001 Dec;21(23):8129-42. doi: 10.1128/MCB.21.23.8129-8142.2001.
2
Myeloproliferative disorder FOP-FGFR1 fusion kinase recruits phosphoinositide-3 kinase and phospholipase Cgamma at the centrosome.骨髓增殖性疾病FOP-FGFR1融合激酶在中心体募集磷酸肌醇-3激酶和磷脂酶Cγ。
Mol Cancer. 2008 Apr 15;7:30. doi: 10.1186/1476-4598-7-30.
3
The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.干细胞增殖性疾病中的t(6;8)(q27;p11)易位使一个新基因FOP与成纤维细胞生长因子受体1融合。
Blood. 1999 Feb 15;93(4):1381-9.
4
FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice.
Blood. 2004 Jan 1;103(1):309-12. doi: 10.1182/blood-2003-05-1690. Epub 2003 Sep 11.
5
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.FGFR1、FGFR3和FGFR4衍生物介导的转化与Stat激活
Oncogene. 2000 Jul 6;19(29):3309-20. doi: 10.1038/sj.onc.1203650.
6
Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.在一种骨髓增殖性疾病中,由于t(8;22)(p11;q11)导致的BCR与成纤维细胞生长因子受体1(FGFR1)基因融合:首个涉及BCR但不涉及ABL的融合基因。
Genes Chromosomes Cancer. 2001 Dec;32(4):302-10. doi: 10.1002/gcc.1195.
7
[FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].[FGFR1和MOZ,两个与8p11 - 12染色体区域重排相关的恶性血液病关键基因]
Bull Cancer. 2000 Dec;87(12):887-94.
8
Downstream effectors of oncogenic ras in multiple myeloma cells.多发性骨髓瘤细胞中致癌性Ras的下游效应分子。
Blood. 2003 Apr 15;101(8):3126-35. doi: 10.1182/blood-2002-08-2640. Epub 2002 Dec 19.
9
Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.由8p11易位产生的ZNF198 - FGFR1和BCR - FGFR1融合基因诱导的独特干细胞骨髓增殖性/ T淋巴瘤综合征
Cancer Cell. 2004 Mar;5(3):287-98. doi: 10.1016/s1535-6108(04)00053-4.
10
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.慢性髓性白血病中的t(8;22)将BCR与FGFR1融合:转化活性及对FGFR1融合蛋白的特异性抑制
Blood. 2001 Dec 15;98(13):3778-83. doi: 10.1182/blood.v98.13.3778.

引用本文的文献

1
The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy.8p11骨髓增殖综合征:基因型和表型分类及靶向治疗。
Front Oncol. 2022 Nov 3;12:1015792. doi: 10.3389/fonc.2022.1015792. eCollection 2022.
2
Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling.致癌性 FGFR 融合通过异位信号产生中心体和纤毛缺陷。
Cells. 2021 Jun 9;10(6):1445. doi: 10.3390/cells10061445.
3
Fibroblast growth factor receptor signaling as therapeutic targets in female reproductive system cancers.成纤维细胞生长因子受体信号传导作为女性生殖系统癌症的治疗靶点
J Cancer. 2020 Oct 21;11(24):7264-7275. doi: 10.7150/jca.44727. eCollection 2020.
4
Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment.靶向成纤维细胞生长因子受体的细胞转运作为选择性癌症治疗策略
J Clin Med. 2018 Dec 20;8(1):7. doi: 10.3390/jcm8010007.
5
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome.FGFR1 融合激酶对 MYC 表达的调控驱动干细胞白血病/淋巴瘤综合征的发生。
Leukemia. 2018 Nov;32(11):2363-2373. doi: 10.1038/s41375-018-0124-y. Epub 2018 Apr 2.
6
[Inhibitory Eefects of the novel tyrosine kinase inhibitor BGJ398 against human leukemic cell line KG-1 cells].新型酪氨酸激酶抑制剂BGJ398对人白血病细胞系KG-1细胞的抑制作用
Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):143-147. doi: 10.3760/cma.j.issn.0253-2727.2018.02.013.
7
Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.使用 OncoScan 染色体拷贝数畸变数据预测早期肝细胞癌。
World J Gastroenterol. 2017 Nov 28;23(44):7818-7829. doi: 10.3748/wjg.v23.i44.7818.
8
Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.成纤维细胞生长因子受体抑制剂TKI258、波纳替尼和AZD4547对TPR-FGFR1融合的活性。
Mol Med Rep. 2017 Mar;15(3):1024-1030. doi: 10.3892/mmr.2017.6140. Epub 2017 Jan 24.
9
Influence of molecular genetics in Vogt-Koyanagi-Harada disease.分子遗传学在Vogt-小柳-原田病中的影响。
J Ophthalmic Inflamm Infect. 2014 Jul 22;4:20. doi: 10.1186/s12348-014-0020-1. eCollection 2014.
10
Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.中心体激酶融合蛋白促进致癌信号传导并破坏骨髓增殖性肿瘤中的中心体功能。
PLoS One. 2014 Mar 21;9(3):e92641. doi: 10.1371/journal.pone.0092641. eCollection 2014.

本文引用的文献

1
Oncogenic kinase signalling.致癌激酶信号传导
Nature. 2001 May 17;411(6835):355-65. doi: 10.1038/35077225.
2
Regulation of translation initiation by FRAP/mTOR.FRAP/mTOR对翻译起始的调控。
Genes Dev. 2001 Apr 1;15(7):807-26. doi: 10.1101/gad.887201.
3
Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development.作为生长、细胞凋亡和乳腺发育调节因子的信号转导及转录激活因子
Breast Cancer Res. 2000;2(2):86-90. doi: 10.1186/bcr38. Epub 2000 Jan 28.
4
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.抑制信号转导和转录激活因子3(STAT3)信号通路会导致白血病大颗粒淋巴细胞凋亡,并降低髓细胞白血病-1(Mcl-1)的表达。
J Clin Invest. 2001 Feb;107(3):351-62. doi: 10.1172/JCI9940.
5
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.激活的成纤维细胞生长因子受体3是一种致癌基因,它在多发性骨髓瘤中促进肿瘤进展。
Blood. 2001 Feb 1;97(3):729-36. doi: 10.1182/blood.v97.3.729.
6
A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.激酶mTOR在癌蛋白P3k和Akt诱导的细胞转化中的作用。
Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):136-41. doi: 10.1073/pnas.98.1.136.
7
The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene.
Br J Haematol. 2000 Nov;111(2):647-9. doi: 10.1046/j.1365-2141.2000.02355.x.
8
Met receptor tyrosine kinase: enhanced signaling through adapter proteins.Met受体酪氨酸激酶:通过衔接蛋白增强信号传导。
Oncogene. 2000 Nov 20;19(49):5582-9. doi: 10.1038/sj.onc.1203859.
9
Suppression of apoptosis induced by growth factor withdrawal by an oncogenic form of c-Cbl.致癌形式的c-Cbl对生长因子撤除诱导的细胞凋亡的抑制作用。
J Biol Chem. 2001 Mar 23;276(12):9028-37. doi: 10.1074/jbc.M009386200. Epub 2000 Dec 11.
10
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.渥曼青霉素、LY294002、槲皮素、杨梅素和星形孢菌素对磷酸肌醇3激酶抑制作用的结构决定因素
Mol Cell. 2000 Oct;6(4):909-19. doi: 10.1016/s1097-2765(05)00089-4.